[Read more...]
U.S. Food and Drug Administration Grants Fast Track Designation to Three Passage Bio Gene Therapy Candidates Targeting Rare CNS Disorders
[Read more...]
FDA Fast Track, ODD, and RPDD Designations for FBX-101 Gene Therapy for Patients with Krabbe Disease
[Read more...]
FDA Clears IND Application for Passage Bio’s Gene Therapy Candidate PBKR03 for Treatment of Patients with Early Infantile Krabbe Disease, A Rare Pediatric Disorder with No Approved Disease-Modifying Treatment Options
[Read more...]
Passage Bio’s PBKR03 Receives Orphan Drug and Rare Pediatric Disease Designations from FDA for Treatment of Krabbe Disease
[Read more...]
Transplant Alone is Not a Cure
[Read more...]
Nikola’s Krabbe Disease Story: Extended Interview
[Read more...]
#curekrabbe “A Million Dreams” Gala
[Read more...]
Together (KrabbeConnect)
[Read more...]
Patient Resources
[Read more...]